{
    "nctId": "NCT05662345",
    "briefTitle": "ACT-MBC: A Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer (MBC)",
    "officialTitle": "ACT-MBC: A Prospective Observational Impact Study of Circulating Tumor Cells (CTCs) in Metastatic Breast Cancer",
    "overallStatus": "RECRUITING",
    "conditions": "Metastatic Breast Cancer",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 65,
    "primaryOutcomeMeasure": "To prospectively evaluate the impact of CellSearch CTCs on treatment decisions and response assessment in MBC patients",
    "eligibilityCriteria": "Inclusion Criteria:\n\n1. Invasive breast cancer with radiographic and/or clinical evidence of advanced metastatic or unresectable disease\n2. ER+/HER2- patients prior to starting 2nd line therapy or beyond OR ER/Progesterone Receptor (PR)/HER2-negative (Triple Negative) patients prior to starting any line of therapy\n3. Measurable and/or non-measurable disease is allowed\n4. Male or female breast cancer is allowed\n5. Age \\> 18 years\n6. Willingness to provide mandatory blood specimens\n7. Willing to return to enrolling institution for follow up imaging at least once\n\nExclusion Criteria:\n\n1. Life expectancy of \u2264 6 months\n2. Inability to provide blood samples based on the judgment of the treating provider",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}